FFJ-38826-27141
3 vaccinations
6 coded responses
11 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 928 / CA
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Registered in v-safe
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Headache, Self-medication — Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesFree text: I'll of the above symptoms approximately 16 hours post 2nd vaccine. Worst was headache. I was taking Tylenol regularly.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-07-16
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral, Tenderness — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Swelling and tenderness in the axilla of the injection armMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: GoodFree text: Swelling in axilla of injection arm still presentMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral, Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Rash to bilateral axilla improving. Swelling to axilla of injection arm also improving.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral, Rash — Feeling: GoodFree text: Still with mild axillary swelling on injection arm. Bilateral axillary rash almost completely gone.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: GoodFree text: Very mild axilla swelling of injection arm.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-06
- 2021-10-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): I'll of the above symptoms approximately 16 hours post 2nd vaccine. Worst was headache. I was taking Tylenol regularly.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Swelling and tenderness in the axilla of the injection arm
Systemic reaction (other): Swelling in axilla of injection arm still present
Systemic reaction (other): Rash to bilateral axilla improving. Swelling to axilla of injection arm also improving.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Still with mild axillary swelling on injection arm. Bilateral axillary rash almost completely gone.
Systemic reaction (other): Very mild axilla swelling of injection arm.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
| SRO | Rash | · | · | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
| SRO | Tenderness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release